To complement the 32 QCRU serology reagents currently CE-marked, we are pleased to announce a further 4 CE-marked reagents produced in response to customer requests.
To aid in the diagnosis of measles (anti-measles IgG), mumps (anti-mumps IgG) and Lyme disease (anti-Lyme IgM and anti-Lyme IgG), these run controls are designed to assure the quality of results obtained during testing of clinical diagnostic serology samples and are suitable for all major automated diagnostic serology platforms as well as most manual assays.
For more information email enquiries@nibsc.org.